These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-term effects of unilateral 6-hydroxydopamine destruction of the dopaminergic nigrostriatal pathway on the urinary excretion of catecholamines (dopamine, norepinephrine, epinephrine) and their metabolites in the rat. Peyrin L, Cottet-Emard JM, Javoy F, Agid Y, Herbet A, Glowinski J. Brain Res; 1978 Mar 31; 143(3):567-72. PubMed ID: 274167 [No Abstract] [Full Text] [Related]
5. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine. Breese GR, Traylor TD. Br J Pharmacol; 1971 May 31; 42(1):88-99. PubMed ID: 5580702 [Abstract] [Full Text] [Related]
6. Excretion of catecholamine metabolites following intraventricular injection of 6-hydroxydopamine in the Macaca speciosa. Maas JW, Dekirmenjian H, Garver D, Redmond DE, Landis DH. Eur J Pharmacol; 1973 Aug 31; 23(2):121-30. PubMed ID: 4200289 [No Abstract] [Full Text] [Related]
7. Selective depletion of cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rat. Teicher MH, Barber NI, Reichheld JH, Baldessarini RJ, Finklestein SP. Brain Res; 1986 Nov 31; 395(1):124-8. PubMed ID: 2430678 [Abstract] [Full Text] [Related]
10. Effects of intracisternal 6-hydroxydopamine treatment on acquisition and performance of rats in a double T-maze. Howard JL, Grant LD, Breese GR. J Comp Physiol Psychol; 1974 Jun 31; 86(6):995-1007. PubMed ID: 4836849 [No Abstract] [Full Text] [Related]
11. 3-methoxy-4-hydroxyphenylglycol excretion and behavioural changes in rat and monkey after central sympathecomy with 6-hydroxydopamine. Breese GR, Prange AJ, Howard JL, Lipton MA, McKinney WT, Bowman RE, Bushnell P. Nat New Biol; 1972 Dec 27; 240(104):286-7. PubMed ID: 4633263 [No Abstract] [Full Text] [Related]
13. Effects of intraventricular 2,4,5-trihydroxyphenylethylamine (6-hydroxydopamine) on rat behaviour and brain catecholamine metabolism. Laverty R, Taylor KM. Br J Pharmacol; 1970 Dec 27; 40(4):836-46. PubMed ID: 5495179 [Abstract] [Full Text] [Related]
15. Effects of intravenously administered 6-hydroxydopamine on the content of monoamines in the median eminence and neurointermediate lobe of the rat. Sheward WJ, Watts AG, Fink G, Smith GC. Neurosci Lett; 1985 Apr 09; 55(2):141-4. PubMed ID: 2582316 [Abstract] [Full Text] [Related]
16. 6-hydroxydopamine destruction of central adrenergic neurones prevents or reverses developing DOCA-salt hypertension in rats. Lamprecht F, Richardson JS, Williams RB, Kopin IJ. J Neural Transm; 1977 Apr 09; 40(2):149-58. PubMed ID: 323422 [Abstract] [Full Text] [Related]
17. Lesions of central norepinephrine terminals with 6-OH-dopamine: biochemistry and fine structure. Bloom FE, Algeri S, Groppetti A, Revuelta A, Costa E. Science; 1969 Dec 05; 166(3910):1284-6. PubMed ID: 5350323 [Abstract] [Full Text] [Related]
18. The importance of central adrenergic neurones in renal hypertension in rabbits. Chalmers JP, Dollery CT, Lewis PJ, Reid JL. J Physiol; 1974 Apr 05; 238(2):403-11. PubMed ID: 4407465 [Abstract] [Full Text] [Related]